Pharmacokinetic and pharmacodynamic interactions between furosemide and hydrochlorothiazide in nephrotic patients

Nephron. 1988;49(3):223-7. doi: 10.1159/000185059.

Abstract

We examined the response of 8 patients with nephrotic syndrome (creatinine clearance 70.4 +/- 16.0 ml/min) to oral furosemide (F; 40 mg) in the absence (control) and in the presence of oral hydrochlorothiazide (HCT; 100 mg). In the 24-hour period after oral F, HCT was shown to increase urine volume and urinary sodium and chloride excretion. Increment was most significant during the 12- to 24-hour period. Enhancement of the diuresis with HCT was associated neither with a significant increase in the area under the curve of plasma F concentration nor an increase in urinary F excretion. Urinary excretion of glucuronidated F, one of the main metabolites of F, however, was decreased with HCT. In summary, HCT significantly enhanced the response to F in nephrotic patients.

MeSH terms

  • Drug Interactions
  • Erythrocytes / analysis
  • Female
  • Furosemide / pharmacokinetics*
  • Furosemide / pharmacology
  • Furosemide / urine
  • Humans
  • Hydrochlorothiazide / analysis
  • Hydrochlorothiazide / pharmacology*
  • Hydrochlorothiazide / urine
  • Male
  • Middle Aged
  • Nephrotic Syndrome / drug therapy*
  • Potassium / urine
  • Sodium / urine
  • Urine

Substances

  • Hydrochlorothiazide
  • Furosemide
  • Sodium
  • Potassium